TSX-V:MIR - TSX Venture Exchange - CA58501R1029 - Common Stock - Currency: CAD
TSX-V:MIR (3/7/2025, 7:00:00 PM)
0.105
0 (0%)
The current stock price of MIR.CA is 0.105 CAD. In the past month the price decreased by -22.22%. In the past year, price increased by 16.67%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 297.70M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 61.95M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 50.50M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 33.97M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 28.76M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 27.68M | ||
ASG.CA | AURORA SPINE CORP | N/A | 24.90M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 17.70M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 15.91M | ||
EVMT.CA | EVOME MEDICAL TECHNOLOGIES I | N/A | 4.81M |
MedMira, Inc. is a biotechnology company, which engages in the development and commercialization of rapid diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The firm is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. The company provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.
MEDMIRA INC
155 Chain Lake Dr.,, Suite 1
Halifax NOVA SCOTIA B3S 1B3 CA
CEO: Hermes Chan
Employees: 52
Company Website: https://medmira.com/
Investor Relations: http://medmira.com/for-investors
Phone: 19024501588
The current stock price of MIR.CA is 0.105 CAD.
The exchange symbol of MEDMIRA INC is MIR and it is listed on the TSX Venture Exchange exchange.
MIR.CA stock is listed on the TSX Venture Exchange exchange.
MEDMIRA INC (MIR.CA) has a market capitalization of 79.62M CAD. This makes MIR.CA a Micro Cap stock.
MEDMIRA INC (MIR.CA) currently has 52 employees.
MEDMIRA INC (MIR.CA) has a support level at 0.09 and a resistance level at 0.12. Check the full technical report for a detailed analysis of MIR.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MIR.CA does not pay a dividend.
MEDMIRA INC (MIR.CA) will report earnings on 2025-03-27.
MEDMIRA INC (MIR.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
ChartMill assigns a technical rating of 4 / 10 to MIR.CA. When comparing the yearly performance of all stocks, MIR.CA is one of the better performing stocks in the market, outperforming 83.92% of all stocks.
Over the last trailing twelve months MIR.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -34.15% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -77.05% | ||
ROE | N/A | ||
Debt/Equity | N/A |